R&D News | pharmaphorum

News

Closeup of X-ray photography of human brain

Study uncovers new Alzheimer's genes, links to immune disrup...

The largest-ever study of genetics in Alzheimer's disease patients has identified 42 new genes that appear to be linked to the neurodegenerative disorder.

News

Hand in glove holding Petri plate with bacteria Steptococcus Phaemolifticus G, Streptococcus Agalactiae, Streptococcus Phaemolifticus

Pharma-backed antibiotic fund makes first investments

Two years after it was first proposed and a year after it officially launched, the pharma-backed AMR Action Fund has made its first investments in companies trying to tackle the pressing pr

News

A New Era of Collaboration and Innovation

AXA arm beefs up life sciences investments with $500m push

The investment arm of multinational insurance company AXA has launched a new €440 million ($500 million) drive to provide private equity investments in healthcare companies that deepens its

News

Illustration of a nerve cell on a colored background with light effects

Vertex Pharma makes progress in quest for non-opioid pain dr...

The search for an alternative to opioid drugs for pain relief has dragged one for decades, with little success, but Vertex Pharma thinks that could be about to change. The company

News

And then there were three; ex-Merck CEO Ken Frazier joins Ei...

The board of Eikon Therapeutics will soon look like Merck & Co's a few years ago – after the big pharma's former CEO Ken Frazier agree to join his former colleagues Roger Perlmutter and

News

group of chemical scientists working at the laboratory.

Canary Wharf makes play to become UK life sciences hub

The organisation behind the iconic Canary Wharf development has said it plans to build one of the largest commercial laboratory facilities in Europe as part of a drive to make the east Lond

Study uncovers new Alzheimer's genes, links to immune disrup...

Pharma-backed antibiotic fund makes first investments

AXA arm beefs up life sciences investments with $500m push

Vertex Pharma makes progress in quest for non-opioid pain dr...

And then there were three; ex-Merck CEO Ken Frazier joins Ei...

Canary Wharf makes play to become UK life sciences hub

Danco fights back after US court curbs abortion pill access

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks